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2. Materials and methods Abstract Biochemical, immunohistochemical nd molecular 
biological methods were used to detect fetal myosin heavy chain 
(MyHC)  in the human masseter of elderly and young subjects. 2.1. Muscle specimens 
Muscle specimens from the anterior and posterior parts of the 
Samples from the elderly subjects contained larger amounts of superficial portion and the deep portion of the masseter muscle and 
fetal MyHC than those of young adults. Only a very small the biceps brachii muscle of six elderly subjects (mean age 74 years, 
amount of embryonic MyHC could be detected in both age 58-83 years) and two young adults (22 and 24 years) were obtained 1- 
groups. Embryonic and fetal MyHCs were never detected in the 3 days post mortem [9]. Additional samples from quadriceps at 16 
control adult orofacial, limb and trunk muscles. Polymerase weeks of development and young adult buccinator and diaphragm 
chain reaction (PCR) analysis revealed the presence of fetal muscles were used for PCR analyses (see below). The investigation 
mRNA sequences in elderly and young masseter muscles. We was approved by Socialstyrelsen, The National Board of Health and 
conclude that fetal MyHC is present in the human masseter Welfare, Stockholm, Sweden. 
throughout the life span and that there is an increase in the 2.2. Enzyme- and immunohistochemistry 
relative amount of this protein with age. The muscle specimens were frozen in liquid propane chilled with 
liquid nitrogen. In a cryostat microtome, 5 10 Bm thick serial cross- 
Key words." Aging; Human;  Masseter;  Muscle; Myosin;  sections, were cut at -20°C and processed for myofibrillar Ca2+-acti- 
mRNA rated adenosine triphosphatase (ATPase, EC 3.6.1.3) at pH 9.4 after 
alkaline (pH 10.3), or acid (pH 4.6, 4.3) preincubations [10]. Fiber 
type classification was based on the staining intensity for ATPase after 
alkaline and acid preincubations according to the following criteria 
(Monemi et al., submitted). At pH 10.3, weakly stained fibers were 
1. Introduction termed type I and moderately to strongly stained fibers type II. After 
acid preincubations, type II fibers were subdivided into IIA (unstained 
Embryonic and fetal myosin heavy chain (MyHC) isoforms or weakly stained at pH 4.6 and unstained at pH 4.3), IIAB (moder- 
are replaced after birth in l imb and trunk muscles by adult ately stained at pH 4.6 and unstained at pH 4.3), IIB (moderately to 
strongly stained at pH 4.6 and unstained at pH 4.3) and IIC (rood- 
slow and fast isoforms of MyHC [1,2]. However, in the hu- erately stained at pH 4.6 and weakly stained at pH 4.3). Fibers with a 
man masseter muscle these myosin isoforms have been shown moderate staining at alkaline pH and moderate to strong at acid pH 
to persist during postnatal  [3] and adult life, mainly within the were labelled type IM. Previously documented, antibodies (Ab) 
populat ion of fibers also containing fast myosin [4-8]. The role against fetal (NN5) [4-7,11] and embryonic (2B6) [6,7,12] MyHC iso- 
forms, were used on cross-sections, erial to those used for enzyme 
of embryonic and fetal MyHCs in masseter muscle contrac- histochemistry. Immunohistochemical detection of the primary anti- 
t ion remains unclear. However, it has been suggested that body was performed with the indirect peroxidase-antiperoxidase 
their presence is related to the unique demands required of (PAP) technique [13]. The PAP products were obtained from Dako- 
the human masseter muscle during the various jaw functions patts (Copenhagen, Denmark). 
and/or to its cranial nerve supply [3,4,6-8]. Muscle cross-sections of each muscle region from elderly subjects 
were photographed in 2-4 areas. Fiber type classification and evalua- 
Recently, we have shown a significant age-related increase tion of immunostaining intensity of fiber types were performed in 
of histochemically defined type II fibers, i.e. fibers containing serial sections at 300× magnification for the masseter and 160× 
fast MyHCs,  in the human masseter of elderly subjects (Mo- for the biceps brachii. More than 10000 fibers were examined. De- 
nemi et al., submitted). To further characterise these fibers tailed analysis of immunoreactivity of fiber types was based on eva- 
luation of 2016 (£= 351, S.D. = 101) fibers in the old masseter, 1909 
and the expression of  the embryonic and fetal MyHCs in fibers (£=318, S.D.=136) in the old biceps and 638 (g=319, 
the human masseter in relation to aging, we have examined S.D. = 28) fibers in the young adult masseter. 
muscle specimens from the masseters of elderly and young 
subjects, using biochemical, molecular biological and enzyme- 2.3. Immunoblotting analysis 
Muscles were extracted as described previously for the native myo- 
and immunohistochemical  techniques. For  comparison the sins [11], denatured with SDS and run on 12% polyacrylamide SDS 
study included orofacial, l imb and trunk muscles, slab gels. The proteins were electrophoretically transferred to nitro- 
cellulose. The paper was incubated with the anti-fetal antibody (1/100) 
and specific binding was revealed with the indirect peroxidase-antiper- 
oxidase technique. 
2.4. Polymerase chain reaction analysis (PCR) 
mRNAs from adult buccinator, diaphragm and elderly and young 
masseters as well as from quadriceps from 20 weeks of development 
*Corresponding author. Fax: (46) (90) 132578; were prepared according to [14]. Random cDNA was prepared from 2 
E-mail: Mehrdad.Monemi@oralphys.umu.se p.g of total mRNA, using random hexaprimers and M-MLV reverse 
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transcriptase for 45 min at 42°C (Gibco). Amplification was per- Table 1 
formed with oligonucleotides specific for the perinatal myosin heavy Percentage (%)of anti-fetal MyHC Ab reactive fibers in various fi- 
chain sequence [15], using Taq-Pol (Gibco) according to the manufac- ber type groups of the old and young human masseter muscle 
turer's instructions. The specificity of the amplified fragment was de- Percentage 
termined by (i) the size of the band as compared to what is expected 
from the sequence, and (ii) restriction of the amplified material with I IM+IIC IIA+IIAB liB 
HinfI (Gibco) (data not shown). Possible DNA amplification was Elderly 4.0 (31.0) 48.0 (16.0) 1.0 (14.0) 39.0 (39.0) 
eliminated by choosing the oligonucleotides in different exons. Ampli- Young adults (62.0) 37.0 (9.0) (2.0) 38.0 (27.0) 
fled fragments were separated on a 6% acrylamide gel. 
Values in parentheses show the relative frequency of fiber types in the 
elderly (Monemi et al., submitted) and young adult [18] masseter. 
3. Results 
3.1. Enzyme- and immunohistochemistry 4. Discussion 
The anti-fetal reactive fibers were in general heteroge- 
neously distributed over the masseter muscle cross-sections. In the present study we show by immunohistochemical and
In the young masseter, anti-fetal immunoreactivity was exclu- biochemical techniques that the fetal MyHC, which was initi- 
sively detected in the type IM+IIC fibers 07=37%0, S.D.=I 1%) ally characterized during muscle development, not only per- 
and the type liB fibers ($=38% , S.D.=20%). In the old mas- sists in the adult human masseter muscle but increases in 
seter, anti-fetal immunoreactivity was preferentially detected relative amount with aging. The result of the PCR analysis 
in the type IM+IIC fibers ($=48% , S.D.=34%o) and the type confirms the presence of fetal MyHC mRNA in the elderly 
IIB fibers ($=39%, S.D.=21%). Only minor populations of the masseter. 
type I fibers (2=4%, S.D.=5.4%) and the type IIA+IIAB fibers The age-related increase in the amount of fetal MyHC in 
()~=1%, S.D.=2%) showed reactivity with the anti-fetal MyHC the masseter muscle could be related to a relative increase of 
Ab (Fig. la-c). A very small proportion of the masseter fibers this myosin isoform within single muscle fibers and/or an in- 
showed immunoreactivity with the anti-embryonic Ab (< 1%). crease in the total number of fibers expressing fetal MyHC. In 
No immunoreactivity was detected in the biceps brachii mus- accordance with previous reports in young adults [5,7], the 
cle specimens, immunoreactivity with the anti-fetal MyHC antibody was 
mainly detected in the type IM, and type II fiber populations 
3.2. lmmunoblotting and in about the same proportions. Thus, the increased 
In Fig. 2 it can be seen that fetal MyHC was present in amount of fetal MyHC in the old masseter should be related 
both old and young masseter muscles. However, the fetal to an increase in the total number of fibers containing fetal 
MyHC band was consistently stronger in all of the older MyHC. In fact, in a recent study carried out on the human 
masseter muscles. Reactivity for fetal MyHC was always ab- masseter of elderly subjects (Monemi et al., submitted) we 
sent in the biceps brachii muscle specimens (data not shown), show that there is an age-related shift in fiber type composi- 
tion, towards a relatively higher proportion of type IM and 
3.3. Polymerase chain reaction (PCR) type II fibers (Table 1). It has been hypothesized that since the 
A specific band of 602 bp, was observed in the elderly masseter muscle is innervated by a cranial nerve and derived 
masseter sample. A band of the same size was present in large from the first branchial arch, this may be responsible for the 
amounts in fetal muscle, but was not detected in either adult different phenotypic expressions of MyHCs in this muscle 
buccinator or diaphragm (Fig. 3). The presence of fetal [3,7]. However, this would not seem to be the reason since 
MyHC mRNA in the masseter sample is therefore confirmed the anterior portion of the human digastric muscle is, like the 
by the detection of the corresponding mRNA. masseter, evolved from the first branchial arch and supplied 
by the same branch of the trigeminal nerve but the fiber type 
. . . . .  . . . . . . . .  . . . . . .  
Fig. 1. Serial cross-sections of the masseter muscle from an elderly subject (78 years) labelled with anti-fetal MyHC antibody followed by PAP 
staining (a,b) and stained for myofibrillar ATPase activity at pH 10.3 (c). Fiber types I, IM, IIC (C), IIAB (AB) and liB (B) have been la- 
belled. Note immunostaining preferentially in the type IM and II fibers. Magnification: (a) X 50, (b,c) square in (a) x 300. Scale bars = 50 ~tm. 
Fig. 2. Immunoblotting analysis of myosin extracted from old (o) and young (y) masseters eacted with antibody specific against fetal MyHC. 
Note thicker bands, i.e. larger amounts of fetal MyHC in the samples from the elderly subjects. 
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Fig. 3. Electrophoresis of PCR products from masseter muscle sample of an 73 year old man (d) after 29 cycles of amplification with oligonu- 
cleotides pecific for the fetal MyHC. For comparison, the mRNA from buccinator (a), diaphragm (b) and quadriceps at 16 weeks of develop- 
ment (c) were used. The marker, is ~x  174, digested by HaelII (Gibco). 
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